Technoderma Medicines
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Technoderma Medicines sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Technoderma Medicines: 5 sponsored US clinical trials, none currently recruiting.
Technoderma Medicines sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alopecia, Androgenetic, with 2 trials.
Upper-quartile sponsor footprint
Technoderma Medicines sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Study of TDM-180935 in Atopic Dermatitis Patients
NCT06363461
Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
NCT05802173
A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male Subjects
NCT05525468
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
NCT05244980
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
NCT04913519
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
Therapeutic Areas
How the Technoderma Medicines early-phase archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Alopecia, Androgenetic (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Technoderma Medicines: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Technoderma Medicines sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Technoderma Medicines page
5 registered trials is a research-attention snapshot, not an endorsement of Technoderma Medicines or any single study.
- None of Technoderma Medicines's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Alopecia, Androgenetic is the condition Technoderma Medicines studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alopecia, Androgenetic trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Technoderma Medicines pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.